GoodGuyBill Tuesday, 05/04/21 10:00:52 PM Re: DavidW2 post# 374273 Post # of 377845 Will the p3 trial, recommended by the FDA, likely be completed by NWBO's tld presentation and BLA submission? Will Gliovac have the data that equals or succeed NWBO's? I doubt it. Quote:"the FDA has recommended early termination of the ongoing Phase 2 clinical trial titled ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma in a letter dated April 2, 2021 (NCT01903330). The FDA further recommended that the parties pursue a randomized confirmatory Phase 3 registration trial to support a licensing application in the form of a biologics license application (BLA)." The only thing necessary for the triumph of evil is for good men to do nothing. We live in a time where too many go beyond doing nothing, they boast about their evil deeds and thank their always-loving God for the opportunity.